Re: GSK withdraws tykerb+herceptin application from FDA
This is frustrating. I understand their reasoning, but I think they had some patients that were very advanced in their disease that might have affected outcome analysis. The decision would still would allow patients to have this combination, but it would be with their doctor agreeing to it and their insurance company agreeeing to cover it. I am waiting to see their data for the clinical trial to understand the decision better. Please do not give up for those that are looking at this treatment.
|